Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,586 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Active, Not Recruiting

ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer

NCT05446298

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Cancer Treatment Centers of America, Phoenix. 403 Goodyear, Arizona, United States
  • Honor Health, USOR, 406 Phoenix, Arizona, United States
  • Nuvance Health System, 401 Danbury, Connecticut, United States
  • Baptist MD Anderson Cancer Center, 404 Jacksonville, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

NCT03772028

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • MSKCC New York New York, United States
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • CHU de Besancon Besançon, France
View all 28 locations
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

NCT03937154

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • Saint Bernards Medical Center Jonesboro, Arkansas, United States
  • Los Angeles Cancer Network Anaheim, California, United States
  • University of California Irvine Orange, California, United States
  • Colorado West Healthcare System dba Grand Valley Oncology Grand Junction, Colorado, United States
View all 139 locations
View Trial Details
Active, Not Recruiting

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

NCT04938583

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Korea Anam Hospital Seoul, South Korea
  • Asan Medical Hospital Seoul, South Korea
  • Seoul St. Mary's Hospital Seoul, South Korea
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

NCT06132958

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • USA Mitchell Cancer Institute ( Site 4142) Mobile, Alabama, United States
  • Alaska Womens Cancer Care ( Site 4122) Anchorage, Alaska, United States
  • HonorHealth (HH) ( Site 8000) Phoenix, Arizona, United States
  • Arizona Oncology Associates - HOPE ( Site 8002) Tucson, Arizona, United States
View all 241 locations
View Trial Details

Related conditions